Charles Schwab’s Beneficient BENF Stock Holding History

Charles Schwab’s Portfolio BENF Stock Details BENF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-59	Closed	-$18.4K	–	3475
2023 Q4	$18.4K	Hold	59	–	–	﹤0.01%	3489
2023 Q3	$98K	Buy	+59	New	+$92.6K	﹤0.01%	3355

Other funds holding BENF

HIP

Hatteras Investment Partners Raleigh, North Carolina $169K AUM 86.49% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

AFP

Ausdal Financial Partners Davenport, Iowa $2.25B AUM 20.11% 1-Year Est. Return

Charles Schwab's BENF Position: Q1 2024 in Review

Charles Schwab sold out of Beneficient (BENF) in Q1 2024, closing a stake of 59 shares — an estimated $18.4K sold.

Charles Schwab first reported a position in BENF in Q3 2023 and held it in 2 quarters. The position peaked at $98K in Q3 2023. 20 funds tracked by Wall St. Rank hold BENF as of Q1 2024.

Charles Schwab reported no remaining Beneficient position as of Q1 2024 after selling out during the quarter.
Charles Schwab sold 59 Beneficient shares in Q1 2024, an estimated $18.4K.
Charles Schwab first reported a position in Beneficient in Q3 2023 and held it in 2 quarters.
Charles Schwab's Beneficient position peaked at $98K in Q3 2023.
20 funds tracked by Wall St. Rank held Beneficient as of Q1 2024.

Based on Charles Schwab's 13F filing for Q1 2024, filed 9 May 2024.